Publikationen
Weitere Informationen zu den Publikationen der AG Prof. Sippl finden sie hier:
2025
Friedrich F, Schiedel M, Swyter S, Zhang L, Sippl W, Schutkowski M, Einsle O, Jung M. Efficient Crystallization of Apo Sirt2 for Small-Molecule Soaking and Structural Analysis of Ligand Interactions. J Med Chem. 2025 May 19. doi:10.1021/acs.jmedchem.4c02896 .
Anne-Christin Sarnow , Husam Nassar , Abdallah Alfayomy , Dina Robaa and Wolfgang Sippl. HADDOCK-Guided Modeling and Molecular Simulations of Cereblon-Based Ternary Complexes: Development of novel PROTACs for Ataxia telangiectasia and RAD3-Related (ATR) kinase
ChemxRiv, preprint https://doi.org/10.26434/chemrxiv-2025-x1982
Mieland AO, Petrosino G, Dejung M, Chen JX, Fulzele A, Mahmoudi F, Tu JW, Mustafa AM, Zeyn Y, Hieber C, Bros M, Schnöder TM, Heidel FH, Najafi S, Oehme I, Hofmann I, Schutkowski M, Hilscher S, Kosan C, Butter F, Bhatia S, Sippl W, Krämer OH. The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cellsLeukemia. 2025 Apr 29. doi:10.1038/s41375-025-02612-8
N. Gajendran, D. Quiceno-Torress, X. Li, B. Weselman, M. Suresh, S. Sebaoui, F. Mahmoudi, M. Durr, S. K. R. Noonepalle, W. Sippl, A. Villagra Selective HDAC10 inhibitor enhances innate antitumor immunity. Cancer Research 85 (8_Supplement_1), 3144-3144, 2025
H. Nassar, C.A. Sarnow, M. Abdelsalam, I. Celik, D. Robaa, W. Sippl. Ternary Complex Modeling, Induced Fit Docking and Molecular Dynamics Simulations as Successful Approach for the Design of VHL-mediated PROTACs for the kinase FLT3. Arch Pharm (Weinheim). 358(4), e3126, 2025. doi:10.1002/ardp.202500102
Çelik C, Özhan Y, Öztürk C, Dede ZS, Citoglu T, Gungor B, Aru B, Gurdal EE, Sippl W, Sipahi H, Tekşen M, Kırmızıbekmez H. Exploring the anti-inflammatory and cytotoxic effects of Valeriana tuberosa constituents: Integrating in vitro and in silico studies. Fitoterapia.184:106604, 2025. doi: 10.1016/j.fitote.2025.106604
Hemida N, El-Gamil DS, ElHady AK, Lin KC, Chang YH, Hilscher S, Schutkowski M, Ibrahim HS, Hamed MM, Chen SH, Chen CH, Abadi AH, Sippl W, Chen PJ, Cheng YS, Abdel-Halim M. Unlocking the Potential of Novel Tetrahydro-β-Carboline-Based HDAC6 Inhibitors for Colorectal Cancer Therapy: Design, Synthesis and Biological Evaluation. Bioorg Chem.160:108454, 2025. doi:10.1016/j.bioorg.2025.108454.
Fathy A, Allam A, ElHady AK, El-Gamil DS, Lin KC, Chang YH, Lee YH, Hilscher S, Schutkowski M, Ibrahim HS, Chen SH, Chen CH, Abadi AH, Sippl W, Chen PJ, Cheng YS, Abdel-Halim M. Development of Potent and Selective Tetrahydro-β-Carboline-Based HDAC6 Inhibitors with Promising Activity Against Triple-Negative Breast Cancer. RSC Med Chem. 2025 Apr 17. doi:10.1039/d5md00086f
Schott A, Simon T, Müller S, Rausch A, Busch B, Glaß M, Misiak D, Dipto M, Elrewany H, Peters LM, Tripathee S, Ghazy E, Müller F, Rolnik RB, Lederer M, Hmedat A, Vetter M, Wallwiener M, Sippl W, Hüttelmaier S, Bley N. The IGF2BP1 oncogene is a druggable m(6)A-dependent enhancer of YAP1-driven gene expression in ovarian cancer. NAR Cancer. 2025 Feb 24;7(1):zcaf006. doi:10.1093/narcan/zcaf006.
A. E. Ehinak, M.M.M. Lobe, C. V. Simoben, I. Tietjen, D. B. Eni, J. Cassel, J. M. Salvino, L. J. Montaner, W. Sippl, S. M. N. Efange, F. Ntie-Kang. An evaluation of spirooxindoles as blocking agents of SARS-CoV-2 spike/ACE2 fusion and M pro inhibitory agents: Synthesis, biological evaluation and computational analysis. Med Chem Res. 34, 895–909, 2025. https://doi.org/10.1007/s00044-025-03386-5
Adardour M, Mustafa AM, Ouba M, Lahcen MA, Seif EM, Ezzat MAF, Zaballos-García E, Mague JT, Hdoufane I, Cherqaoui D, Krämer OH, Sippl W, Ibrahim HS, Baouid A. Design, synthesis and molecular modeling of new Pyrazolyl-Benzimidazolone hybrids targeting breast Cancer. Bioorg Chem. 157:108269, 2025. doi:10.1016/j.bioorg.2025.108269 .
Jungwirth J, Mieland AO, Piée-Staffa A, Heimburg T, Brenner W, Ehrhardt C, Sippl W, Henke A, Krämer OH. Pharmacologically induced proteolysis of histone deacetylase-6 attenuates influenza virus replication despite limited anti-tumor effects. Life Sci. 363:123401, 2025. doi:10.1016/j.lfs.2025.123401.
Çelik C, İdiş ÖD, Özhan Y, Tirpanlar D, Unal N, Gungor B, Aru B, Gurdal EE, Sippl W, Sipahi H, Kırmızıbekmez H. Isolation of anti-inflammatory and cytotoxic secondary metabolites from Valeriana phu and evaluation of their mechanisms of action. Fitoterapia.181:106377, 2025. doi:10.1016/j.fitote.2025.106377 .
Waitman KB, Martin HJ, Carlos JAEG, Braga RC, Souza VAM, Melo-Filho CC, Hilscher S, Toledo MFZJ, Tavares MT, Costa-Lotufo LV, Machado-Neto JA, Schutkowski M, Sippl W, Kronenberger T, Alves VM, Parise-Filho R, Muratov EN.Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment. bioRxiv [Preprint]. 2024 Dec 5:2024.11.30.626092. doi:10.1101/2024.11.30.626092.
C. Vorreiter, D. Robaa, W. Sippl. Predicting Fragment Binding Modes Using Customized Lennard-Jones Potentials in Short Molecular Dynamics Simulations. Computational and Structural Biotechnology Journal. 27, 102-116, 2025. doi.org/10.1016/j.csbj.2024.12.017